Aknal Injection contains Nalbuphine | belongs to Opioid analgesic
Aknal Injection 10 mg/mL 10 Amp interact with an opiate receptor site in the CNS (probably in or associated with the limbic system). The opiate antagonistic effect may result from competitive inhibition at the opiate receptor
Administered by SC, IM, or IV injection. For direct IV injection through an IV line with a compatible infusing solution, give drug slowly not more than 10 mg over 3 to 5 mins.
Compatibility: Dextrose 5% in NaCl 0.9%, Dextrose 5%, 0.9% NaCl, LR. Incompatible with diazepam or pentobarbital. Use separate IV line or flush line well before and after administration.
Stability: Stable for 48 hours when diluted in 1:1 and 1:2 ratios with diluents.
Children: Initially, up to 0.3 mg/kg by IV, IM or SC inj. Dose may be repeated once or twice if necessary.
Sedation, sweating, nausea, dizziness, dry mouth.
Pain: Adults: 10-20 mg by IV, IM or SC inj.
Myocardial infarction: Adults: 10-30 mg by slow IV inj. A repeat dose of 20 mg may be given within 30 min, if necessary.
Children: Not recommended.
One of the following licensed pharmacy from the nearest location will deliver Aknal Injection 10 mg/mL 10 Amp. The details of the licensed pharmacy shall be shared once you request the drugs and the respective pharmacy accepts the your request based on valid prescription and availability.